HCV INFECTİON AND TREATMENT RATES İN OPİOİD DEPENDENT PATİENTS HOSPİTALİZED İN AN ALCOHOL AND DRUG ADDİCTİON TREATMENT CENTER CLİNİC
Keywords:
Addiction, infection, hepatitis C, opioidAbstract
Objective: The aim of this study was to investigate the factors related with anti HCV positivity rates and post discharge hepatitis C infection follow-up and treatment rates of the patients who was diagnosed with opioid use disorder.
Method: The data of this study was collected by retrospective examination of the records of 265 patients aged 18 and over who were diagnosed with opioid use disorder according to DSM-5 diagnostic criteria and received inpatient treatment in an Alcohol and Drug Addiction Treatment Center (ADATC) clinic between 2017 and 2018.
Results: Anti HCV was positive in all male gender and 10.9% (n=29) patients. It was found that 6.9% (n=2) of the anti HCV positive patients continued their regular outpatient controls after discharge, while anti HCV negative patients came to regular controls at a statistically significant rate with 25.1% (n=59). As a result of the orientation after discharge, 31% of anti HCV positive patients applied to the department of infectious diseases, and 44.4% (n=4) of applicants received direct antiviral therapy.
Conclusion: Treatment compliance of the patients with anti HCV positivity was insufficient in terms of both opioid use and hepatitis C infection. New strategies should be developed to struggle HCV infection in addicted patients in order to direct the patients to treatment, to stay in treatment and to ensure their regular follow-up.
References
Sezak N, Tosun S, Eriş N, Ayer A. Ruh sağlığı hastanesinde yatarak tedavi gören hastalarda hepatit B ve hepatit C infeksiyonlarının sıklığı ve buna etkili faktörlerin değerlendirilmesi. Klimik Derg 2011; 24: 154-157.
Yetim A, Sahin M. İntravenöz madde bağımlısı gençlerde hepatit C virusu (HCV) infeksiyonu: sosyodemografik değerlendirme ve HCV genotip analizi. Klimik Derg 2018; 31: 190–194.
Davis SM, Daily S, Kristjansson AL, et al. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: A systematic review with meta-analysis. Harm Reduct J 2017; 14: 1–15.
Evren C, Bilici R, Ucbilek E, Inan D. A call to action for the prevention of hepatitis C infection among intravenous drug users in Turkey. Dusunen Adam 2017; 30: 271–277.
Anagnostou O, Fotiou A, Kanavou E, et al. Factors associated with HCV test uptake in heroin users entering substitution treatment in Greece. HIV Medicine 2018; 19: 34–39.
Kulaksızoğlu B, Kara H, Özçelik Ö, Kuloğlu M. Opioid bağımlılığının tedavisinde naltrekson implant kullanımı: Geriye dönük bir çalışma. Anadolu Psikiyatri Derg 2019; 20: 133-138.
Mırsal H, Kalyoncu ÖA, Pektaş Ö, et al. Damar yolundan eroin kullananlarda hepatit B, hepatit C ve HIV yaygınlığı. Bağımlılık Dergisi 2003; 4: 10–14.
Altuğlu İ, Tanyeri S, Zeytinoğlu A, Altıntoprak AE. Madde kullanımı olan olgularda HBsAg, Anti-HCV ve Anti-HIV seroprevalansı: Retrospektif bir değerlendirme. Noropsikiyatri Ars 2019; 56: 186-190.
Cummins CA, Erlyana E, Fisher DG, Reynolds GL. Hepatitis C infection among Hispanics in California. J Addict Dis. 2015; 34: 263–273.
Lewer D, Tweed EJ, Aldridge RW, Morley KI. Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks. Drug Alcohol Depend 2019; 204: 1-5.
Wang X, Zhang T, Ho WZ. Opioids and HIV/HCV infection. J Neuroimmune Pharmacol 2011; 6: 477– 489.
Lee J, Conniff J, Kraus C, Schrager S. A brief clinical update on hepatitis C. WMJ 2015; 114: 263–270.
Amerikan Psikiyatri Birliği. Ruhsal Bozuklukların Tanısal ve Sayımsal El Kitabı (DSM-5), Köroğlu E (Çeviri editör). 5. Baskı, Ankara: Hekimler Yayın Birliği, 2013.
Su S, Mao L, Zhao J, et al. Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China. Sci Rep 2018; 8: 1–10.
Berbesi-Fernández DY, Segura-Cardona AM, Montoya-Velez LP, Santamaría AÁ. Use of injected heroin and risk of hepatitis C in three cities in Colombia. Rev Bras Epidemiol 2017; 20 :435-444.
Baluku M, Wamala T, Buhangi D. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming. Harm Red J 2019; 16(1): 56.
Uğurlu TT. Psikodrama grup terapisinin opioid bağımlılığında remisyon ve depreşme üzerine etkisi. Psikodrama Bitirme Tezi. İzmir: Dr Abdülkadir Özbek Psikodrama Enstitüsü, 2019.
Akyar E, Seneca KH, Akyar S, et al. Linkage to care for suburban heroin users with hepatitis C virus İnfection, New Jersey, USA. Emerg Infect Dis 2016; 22: 907–909.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...